Search Within

Isabelle C Riviere

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (6)
Groups
  1. Center for Hematologic Malignancies (16)
  2. Department of Medicine (16)
  3. Department of Pathology and Laboratory Medicine (16)
  4. Hematologic Malignancies Research (16)
  5. Hematologic Malignancies, Division of (16)
  6. GSK Faculty (15)

More Groups

People
  1. Xiuyan Wang (13)
  2. Jae Park (12)
  3. Renier Brentjens (12)
  4. Michel Sadelain (11)
  5. Brigitte Senechal (10)
  6. Ahmet Dogan (8)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (3)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Blood (6)
  2. New England Journal of Medicine (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Cancer Discovery (1)
  5. Clinical Lymphoma, Myeloma and Leukemia (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Elsevier Inc. (2)
  3. Massachusetts Medical Society (2)
  4. American Association for Cancer Research (1)
  5. American Association for the Advancement of Science (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia
    Journal Article

    Park, J. H.; Rivière, I.; Gonen, M.; Wang, X.; Sénéchal, B.; Curran, K. J.; Sauter, C.; Wang, Y.; Santomasso, B.; Mead, E.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Off-the-shelf tumor immunotherapy with genetically enhanced allogeneic T-cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
    Journal Article

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Nature Biotechnology (2008)

    Fulltext@MSK | Save
  • Targeted 'Off-the-Shelf' tumor immunotherapy using allogeneic T-Cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Lu, S. X.; Cabrera-Perez, J.; more...
    Blood (2007)

    Fulltext@MSK | Save